Chemify and Sanacor Collaborate to Discover and Develop Small Molecule Therapies for Cardiometabolic Diseases

Contributed by: Business Wire

Logo

Tags

Technology

Biotechnology

FDA

Nanotechnology

Diabetes

Health

Other Science

Research

Software

Genetics

Hardware

Science

Clinical Trials

Cardiology

Sanacor

More Like This

Researchers at Chemify’s first Chemifarm—a fully automated chemistry facility regarded as the world’s most advanced laboratory for molecular design and synthesis, which opened in Glasgow, Scotland in June of 2025. Chemify, the deep-tech pioneer fusing chemistry, robotics, computation, and Chemputation—Chemify’s purpose-built AI to digitize molecule creation—announced today it has raised over $50 million in Series B funding to help accelerate its mission of becoming the global leader in digital chemistry, molecular design and manufacturing. Co-led by Wing Venture Capital and Insight Partners, the financing will scale Chemify’s Chemputation platform and Chemifarm facilities, transforming how molecules are designed and made for medicines and advanced materials.

Chemify Raises More Than $50 Million in Oversubscribed Series B to Drive Global Expansion of Digital Chemistry and Discovery

Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis

Zeon Corporation Makes Strategic Investment in Chemify to Accelerate Digital Chemistry Innovation and Drive Development of New Materials Through State-of-the-Art Automated Molecular Design and Synthesis

https://chemify.reportablenews.com/pr/chemify-launches-the-world-s-first-chemputation-facility-revolutionizing-molecular-design-and-manufacture

Chemify Launches the World's First Chemputation Facility Revolutionizing Molecular Design and Manufacture

Prepaire Labs is a pioneering healthcare technology company focused on revolutionizing drug discovery and precision medicine. Through the integration of deep learning and biology, Prepaire Labs builds predictive models grounded in genetic, phenotypic, and clinical data. These models form a view to the underlying architecture and biology of diseases. Prepaire Labs utilizes patient-derived induced pluripotent stem cells (iPSCs), genome editing, high-content cellular phenotyping, and machine learning to create in vitro disease models for increased predictability of human clinical outcomes. A state-of-the-art BSL3 lab is opening in May 2024, located at Masdar City, Abu Dhabi, UAE. This will serve as the new fully automated LAAS (Lab As A Service) hub and provide clinical trials on a chip using latest microfluidic devices combined with the ability to print organoid bio-networks. Visit www.prepaire.com to learn more. (Photo: Business Wire)

Chemify Partners with Prepaire Labs to Apply Ground-breaking Chemistry AI-Robotics to Radically Accelerate the Discovery of Non-Addictive Opioids

PR Newswire associated0

Neomorph Announces Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for Cardiometabolic and Rare Diseases

Chemify, a deep tech chemical science company combining chemistry, robotics and AI at scale to digitally design, discover and make new molecules, announced today that Michael Bell has joined as Chief Technology Officer. As a well-known technology veteran in the digital computing industry who helped lead the creation of the Apple iPhone and the launch of Intel’s mobile devices, Mr. Bell will help accelerate the capabilities of Chemify’s digital chemistry platform and the world’s first chemical programming language. (Photo: Business Wire)

Former Apple and Intel Executive Michael Bell Joins Chemify as Chief Technology Officer

Chemify, a deep tech chemical science company combining chemistry, robotics and AI at scale to digitally design, discover and make new molecules, announced today that Dr. Alastair Leighton has joined as Chief Operating Officer (COO). With almost three decades in the biopharma industry working at leading global pharmaceutical companies, Dr. Leighton brings a wealth of experience in manufacturing, supply chain operations and commercial strategy. (Photo: Business Wire)

Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer